Skip to main content

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in WST — West Pharmaceutical Services Inc

CIK 1632972 PLYMOUTH, MN

Position in WST

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$5,175,703
+$2,245,221 QoQ
Shares Held
14,417
+23.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 89 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority Sole 2.4968789013732833.ToString("F0")% Shared 0.ToString("F0")% None 97.50312109862672.ToString("F0")%

Common Shares in WST Over Time

Shares Held

Position Value (USD)

Derivatives in WST

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$825,700
PutShares
2,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Instruments & Supplies

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $108,204,630 across 26 Medical Instruments & Supplies names. WST ranks #5 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 WST
West Pharmaceutical Services Inc
This page
14,417 $5,175,703

All Filings in WST

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,175,703 14,417
2026-06-30 $825,700 2,300
2026-03-31 $2,930,482 11,692
2025-12-31 $5,910,007 21,480
2025-09-30 $7,652,953 29,173
2025-06-30 $5,809,577 26,552
2025-03-31 $6,253,863 27,934
2024-12-31 $9,909,345 30,252
2024-09-30 $930,496 3,100
2024-09-30 $9,493,160 31,627
2024-06-30 $10,629,085 32,269
2024-06-30 $1,021,109 3,100
2024-03-31 $1,305,843 3,300
2024-03-31 $14,547,091 36,762
2023-12-31 $598,604 1,700
2023-12-31 $13,051,327 37,065
2023-09-30 $13,867,761 36,960
2023-09-30 $1,876,050 5,000
2022-09-30 $1,569,498 6,378
2022-06-30 $1,138,423 3,765
2021-06-30 $1,471,950 4,099
2021-03-31 $1,010,181 3,585
2020-12-31 $975,719 3,444
2020-06-30 $1,367,790 6,021